Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Saved in:
| Title: | Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. |
|---|---|
| Authors: | Ebrahimi H; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Dizman N; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; MD Anderson Cancer Center, Houston, TX, USA., Meza L; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Yale University School of Medicine, New Haven, CT, USA., Malhotra J; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Li X; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Dorff T; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Frankel P; Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Llamas-Quitiquit M; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Hsu J; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Zengin ZB; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Yale University School of Medicine, New Haven, CT, USA., Alcantara M; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Castro D; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Mercier B; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Chawla N; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Chehrazi-Raffle A; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Barragan-Carrillo R; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Jaime-Casas S; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Govindarajan A; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Gillece J; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA., Trent J; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA., Lee PP; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Parks TP; Osel, Inc., Mountain View, CA, USA., Takahashi M; Miyarisan Pharmaceutical Co., Ltd, Tokyo, Japan., Hayashi A; Miyarisan Pharmaceutical Co., Ltd, Tokyo, Japan., Kortylewski M; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Caporaso JG; Translational Genomics Research Institute (TGen), Flagstaff, AZ, USA., Lee K; Translational Genomics Research Institute (TGen), Flagstaff, AZ, USA., Tripathi A; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. atripathi@coh.org., Pal SK; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. spal@coh.org. |
| Source: | Nature medicine [Nat Med] 2024 Sep; Vol. 30 (9), pp. 2576-2585. Date of Electronic Publication: 2024 Jun 28. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38942995 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ebrahimi+H%22">Ebrahimi H</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Dizman+N%22">Dizman N</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Meza+L%22">Meza L</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Malhotra+J%22">Malhotra J</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Dorff+T%22">Dorff T</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Frankel+P%22">Frankel P</searchLink>; Department of Biostatistics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Llamas-Quitiquit+M%22">Llamas-Quitiquit M</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+J%22">Hsu J</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zengin+ZB%22">Zengin ZB</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Yale University School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Alcantara+M%22">Alcantara M</searchLink>; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Castro+D%22">Castro D</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mercier+B%22">Mercier B</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chawla+N%22">Chawla N</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chehrazi-Raffle+A%22">Chehrazi-Raffle A</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Barragan-Carrillo+R%22">Barragan-Carrillo R</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Jaime-Casas+S%22">Jaime-Casas S</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Govindarajan+A%22">Govindarajan A</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gillece+J%22">Gillece J</searchLink>; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Trent+J%22">Trent J</searchLink>; Translational Genomics Research Institute (TGen), Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Lee+PP%22">Lee PP</searchLink>; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Parks+TP%22">Parks TP</searchLink>; Osel, Inc., Mountain View, CA, USA.<br /><searchLink fieldCode="AU" term="%22Takahashi+M%22">Takahashi M</searchLink>; Miyarisan Pharmaceutical Co., Ltd, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hayashi+A%22">Hayashi A</searchLink>; Miyarisan Pharmaceutical Co., Ltd, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kortylewski+M%22">Kortylewski M</searchLink>; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Caporaso+JG%22">Caporaso JG</searchLink>; Translational Genomics Research Institute (TGen), Flagstaff, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Lee+K%22">Lee K</searchLink>; Translational Genomics Research Institute (TGen), Flagstaff, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Tripathi+A%22">Tripathi A</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. atripathi@coh.org.<br /><searchLink fieldCode="AU" term="%22Pal+SK%22">Pal SK</searchLink>; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. spal@coh.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2024 Sep; Vol. 30 (9), pp. 2576-2585. <i>Date of Electronic Publication: </i>2024 Jun 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38942995 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-024-03086-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2576 Titles: – TitleFull: Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ebrahimi H – PersonEntity: Name: NameFull: Dizman N – PersonEntity: Name: NameFull: Meza L – PersonEntity: Name: NameFull: Malhotra J – PersonEntity: Name: NameFull: Li X – PersonEntity: Name: NameFull: Dorff T – PersonEntity: Name: NameFull: Frankel P – PersonEntity: Name: NameFull: Llamas-Quitiquit M – PersonEntity: Name: NameFull: Hsu J – PersonEntity: Name: NameFull: Zengin ZB – PersonEntity: Name: NameFull: Alcantara M – PersonEntity: Name: NameFull: Castro D – PersonEntity: Name: NameFull: Mercier B – PersonEntity: Name: NameFull: Chawla N – PersonEntity: Name: NameFull: Chehrazi-Raffle A – PersonEntity: Name: NameFull: Barragan-Carrillo R – PersonEntity: Name: NameFull: Jaime-Casas S – PersonEntity: Name: NameFull: Govindarajan A – PersonEntity: Name: NameFull: Gillece J – PersonEntity: Name: NameFull: Trent J – PersonEntity: Name: NameFull: Lee PP – PersonEntity: Name: NameFull: Parks TP – PersonEntity: Name: NameFull: Takahashi M – PersonEntity: Name: NameFull: Hayashi A – PersonEntity: Name: NameFull: Kortylewski M – PersonEntity: Name: NameFull: Caporaso JG – PersonEntity: Name: NameFull: Lee K – PersonEntity: Name: NameFull: Tripathi A – PersonEntity: Name: NameFull: Pal SK IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2024 Sep Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 30 – Type: issue Value: 9 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |